Analyte sensing for eye injuries and conditions

• US 10,400,262 B2
• Filed: 04/01/2016
• Issued: 09/03/2019
• Est. Priority Date: 04/01/2015
• Status: Active Grant

• Current Assignee: Board of Trustees of The University of Illinois, Carle Health Care Incorporated (Carle Foundation)
• Original Assignee: Board of Trustees of The University of Illinois
• Inventors: Pan, Dipanjan, Misra, Santosh Kumar, Gartia, Manas Ranjan, Labriola, Leanne T.
• Primary Examiner(s): Mekhlin, Eli S
• Application Number:
  US15/562,647
• Publication Number:
  US 20180105857A1
• Time in Patent Office: 1,250 Days
• CPC Class Codes: B82Y 15/00 Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
• CPC Class Codes: C12Q 1/00 Measuring or testing processes involving enzymes, nucleic acids or microorganisms measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34; Compositions therefor; Processes of preparing such compositions
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence
• CPC Class Codes: G01N 2333/90235 Ascorbate oxidase (1.10.3.3)
• CPC Class Codes: G01N 27/3278 involving nanosized elements, e.g. nanogaps or nanoparticles nanopores G01N33/48721; magnetic beads G01N27/745
• CPC Class Codes: G01N 2800/16 Ophthalmology
• CPC Class Codes: G01N 33/48707 by electrical means G01N33/49, G01N33/493 take precedence
• CPC Class Codes: G01N 33/50 Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q

Abstract

A biosensor for the detection of an analyte such as ascorbic acid is provided. Also provided is a device comprising the biosensor. In addition, methods of detecting analytes such as ascorbic acid in a sample, and methods of a point-of-care diagnosis of eye disease and eye injury are provided.

Claims

1. A biosensor for the detection of an analyte, the biosensor comprising:

a layer comprising a mixture of graphene nanoplatelets and one or more polymers, wherein the polymers are amphiphilic block copolymers, a layer of a ligand for the analyte in contact with hydrophilic blocks of the amphiphilic block copolymers;

at least one sensor electrode; and

a substrate.

2. The biosensor of claim 1, wherein the at least one sensor electrode is between the layer comprising a mixture of graphene nanoplatelets and one or more polymers and the layer of a ligand for the analyte.

3. The biosensor of claim 1, wherein the analyte is ascorbic acid and the ligand for the analyte is ascorbate oxidase.

4. The biosensor of claim 3, wherein the ascorbate oxidase is present at a concentration at about 3 to about 100 U/cm².

5. The biosensor of claim 1, wherein the substrate is selected from one or more of filter paper, acrylamide, cellulose, nitrocellulose, glass, silicon wafer, indium tin oxide, mica, polystyrene, or polyvinylidene fluoride (PVDF) filter, glass fiber filters, fiberglass, polyethylimine coated glass fiber filters, porous mylar, transparent porous film, cellulose nitrate (CN) membrane, mixed cellulose ester membrane, cellulose acetate membrane, polyethersulfone (PES) membrane, PTFE membrane, ultrafiltration membranes of poly(vinyl chloride) (PVC), carboxylated poly(vinyl chloride) (CPVC), polystyrene, polyethylene vinyl acetate, polypropylene, polymethacrylate, polyethylene, polyethylene oxide, polysilicates, polycarbonates, teflon, fluorocarbons, nylon, silicon rubber, polyanhydrides, polyglycolic acid, polylactic acid, polyorthoesters, polypropylfumerate, collagen, glycosaminoglycans, and polyamino acids.

6. The biosensor of claim 1, wherein the one or more polymers is poly(styrene) block-poly (acrylic acid) (PS-b-PAA).

7. The biosensor of claim 1, further comprising a fluidics chamber.

8. The biosensor of claim 1, further comprising a cover.

9. A method of using the biosensor of claim 1 for detecting an analyte in a sample comprising contacting the biosensor with the sample and detecting the analyte with a detector.

10. The method of claim 9, wherein the detector detects binding or interaction of the analyte and the analyte ligand due to a change in electrical resistance caused by binding or interaction of the analyte in the sample with the analyte ligand;

due to a change in mass on the biosensor;

due to a colorimetric change;

due to a fluorescent reaction;

due to a change in a Raman spectroscopy reading;

due to a change in a Fourier transform infrared spectroscopy reading, due to a change in a mass spectrometry reading, or due to electrochemical changes.

11. The method of claim 9, wherein the sample is tears, tear film, aqueous layer of the tear film, aqueous humor, sweat, blood, serum, plasma, urine, saliva, or other bodily fluids.

12. A method of using the biosensor of claim 1 for detecting an analyte in a sample, comprising contacting a sample with the biosensor, and inserting the biosensor into or onto a device comprising a detector to measure change in electrical resistance, and a screen for visualizing the change in resistance, thereby detecting an analyte in the sample.

13. The method of claim 12, wherein the amount of the analyte in the sample is detected.

14. A method of using the biosensor of claim 1 for diagnosing an aqueous humor leak, comprising contacting the biosensor with a tear, tear film, aqueous layer of the tear film, or aqueous humor sample of a subject, detecting an amount of an analyte in the sample, and diagnosing an eye condition in the subject where the concentration of the analyte in the sample is elevated as compared to a control sample or control standard.

15. A method of using the biosensor of claim 1 for diagnosing an eye condition in a subject comprising contacting the biosensor with a tear film sample of a subject, detecting an amount of ascorbic acid in the tear film sample from the subject and diagnosing an eye condition in the subject where the amount of ascorbic acid is elevated as compared to a control standard or control sample.

16. The method of claim 14, wherein the analyte is ascorbic acid.

17. A device comprising a biosensor comprising a layer comprising a mixture of graphene nanoplatelets and one or more polymers, wherein the polymers are amphiphilic block copolymers, a layer of a ligand for an analyte in contact with hydrophilic blocks of the amphiphilic block copolymers;

at least one sensor electrode;

a substrate; and

a detector connected to a data acquisition system.

18. The device of claim 17, wherein the detector is a multimeter.

19. The device of claim 17, wherein the data acquisition system is selected from the group consisting of a computer, a hand-held device, a cell phone, and a tablet.

20. The device of claim 17, further comprising a screen that allows for visualization of an amount of analyte present in a sample.